FindTrial
Sign In

A clinical trial to study the two routes of administration dexmedetomidine as an adjuvant to local anaesthetic in spinal anaesthesia

To compare the effect of intrathecal and intravenous dexmedetomidine on spinal anaesthesia for infraumbilical surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055122
Enrollment
78
Registered
2023-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS- Health Condition 2: 8- Other Procedures

Interventions

Control Intervention1: NIL: NIL

Sponsors

Monika Kannan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients with ASA physical status I and II undergoing elective lower abdominal and lower limb surgeries under subarachnoid block

Exclusion criteria

Exclusion criteria: 1.Contraindications to spinal anaesthesia 2.Morbidly obese 3.Known allergy to study drugs or their constituents 4.Presence of preoperative bradycardia and heart blocks

Design outcomes

Primary

MeasureTime frame
To compare the effects of intrathecal & intravenous dexmedetomidine on duration of analgesia & sensory & motor blockade during subarachnoid blockTimepoint: From time of intrathecal injection upto 10 hrs post spinal—

Secondary

MeasureTime frame
To compare the effect of intrathecal & intravenous dexmedetomidine on haemodynamic parameters, incidence of post operative shivering & adverse effects if any Timepoint: From time of intrathecal injection upto 10 hrs post spinal & 24 hrs post procedure—

Countries

India

Contacts

Public ContactMonika Kannan

NITTE University

avanishbhandary@gmail.com9845679949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026